,
,
,
,
,
,
,
,
,
,
,
,
,
Facteurs pronostiques : étude de la littérature et comparaison avec notre étude, p.49 ,
,
,
, Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision, Joint Task Force of the EFNS and the PNS, vol.15, pp.295-301, 2010.
Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies, Clin Neurophysiol, vol.124, issue.10, pp.1928-1962, 2013. ,
Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy, Neurology, vol.75, issue.9, pp.818-843, 2010. ,
Intravenous immunoglobulin as short-and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients, Neurosurgery & Psychiatry, vol.79, issue.1, pp.93-99, 2008. ,
The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy, Brain, vol.121, pp.421-429, 1998. ,
Treatment of IgM antibody associated polyneuropathies using rituximab, J Neurol Neurosurg Psychiatry, vol.74, issue.4, pp.485-494, 2003. ,
An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy, J Peripher Nerv Syst, vol.15, issue.3, pp.196-201, 2010. ,
Amélioration d'un cas de neuropathie motrice multifocale avec blocs de conduction sévère, 2011. ,
Beneficial effect of rituximab monotherapy in multifocal motor neuropathy, Neuromuscul Disord, 2009. ,
Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies, Nat Rev Neurol, vol.8, issue.1, pp.48-58, 2012. ,
DOI : 10.1038/nrneurol.2011.175
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy. Cochrane Database Syst Rev, p.3217, 2015. ,
DOI : 10.1002/14651858.cd003217.pub4
URL : https://air.unimi.it/bitstream/2434/288120/2/60791e4af428afc4498c9a8ae074631db85ea30ffe9897f4e2a2b103bfd20f2d.pdf
Immunotherapy of multifocal motor neuropathy, Expert Opin Biol Ther, vol.11, issue.3, pp.329-371, 2011. ,
DOI : 10.1517/14712598.2011.548798
Treatment of multifocal motor neuropathy, Curr Treat Options Neurol, vol.16, issue.2, p.269, 2014. ,
Axon loss is an important determinant of weakness in multifocal motor neuropathy, J Neurol Neurosurg Psychiatry, vol.77, issue.6, pp.743-750, 2006. ,
Long term follow up of multifocal motor neuropathy with conduction block under treatment, J Neurol Neurosurg Psychiatry, vol.62, issue.4, pp.391-395, 1997. ,
Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment, Ann Neurol, vol.48, issue.6, pp.919-945, 2000. ,
Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block, J Neurol Neurosurg Psychiatry, vol.72, issue.6, pp.761-767, 2002. ,
Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry, Ther Adv Neurol Disord, vol.9, issue.3, pp.165-79, 2016. ,
Multifocal motor neuropathy, J Neuroimmunol, vol.115, issue.12, pp.4-18, 2001. ,
How long is IVIg effective in multifocal motor neuropathy? Neurology, vol.62, pp.666-674, 2004. ,
, ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8-10, vol.23, pp.924-957, 2013.
Chronic inflammatory demyelinating polyneuropathy disease activity status: recommendations for clinical research standards and use in clinical practice, J Peripher Nerv Syst, vol.15, issue.4, pp.326-359, 2010. ,
Disease status in chronic inflammatory demyelinating polyneuropathy: inter-centre comparative analysis and correlates, Eur J Neurol, vol.22, issue.11, pp.1469-73, 2015. ,
Outcome measures in MMN revisited: further improvement needed, J Peripher Nerv Syst, vol.20, issue.3, pp.306-324, 2015. ,
Multifocal motor neuropathy Association of anti-GM1 IgM antibodies with clinical features, Neurology, vol.75, issue.22, pp.1961-1968, 2010. ,
, Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-first revision, Joint Task Force of the EFNS and the PNS, vol.15, pp.295-301, 2010.
Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies, Clin Neurophysiol. oct, vol.124, issue.10, pp.1928-1962, 2013. ,
Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy, Neurology. 31 août, vol.75, issue.9, pp.818-843, 2010. ,
Intravenous immunoglobulin as short-and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients, Neurosurgery & Psychiatry. 1 janv, vol.79, issue.1, pp.93-99, 2008. ,
Beneficial effect of rituximab monotherapy in multifocal motor neuropathy, Neuromuscul Disord. juill, vol.19, issue.7, pp.473-478, 2009. ,
Treatment of IgM antibody associated polyneuropathies using rituximab, J Neurol Neurosurg Psychiatry. avr, vol.74, issue.4, pp.485-494, 2003. ,
An open-label trial of rituximab (Rituxan®) in multifocal motor neuropathy, J Peripher Nerv Syst. sept, vol.15, issue.3, pp.196-201, 2010. ,
Immunotherapy of multifocal motor neuropathy, Expert Opin Biol Ther. mars, vol.11, issue.3, pp.329-371, 2011. ,
Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy, Cochrane Database Syst Rev. mars, issue.3, p.3217, 2015. ,
Multifocal motor neuropathy: diagnosis, pathogenesis and treatment strategies, Nat Rev Neurol. janv, vol.8, issue.1, pp.48-58, 2012. ,
Treatment of multifocal motor neuropathy, Curr Treat Options Neurol. févr, vol.16, issue.2, p.269, 2014. ,
Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia, Eur Neurol, vol.25, issue.6, pp.416-439, 1986. ,
DOI : 10.1159/000116045
Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome, Neurology. sept, vol.36, issue.9, pp.1260-1263, 1986. ,
Multifocal acquired demyelinating neuropathy masquerading as motor neuron disease, Muscle Nerve. févr, vol.11, issue.2, pp.103-110, 1988. ,
DOI : 10.1002/mus.880110203
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside, Ann Neurol. juill, vol.24, issue.1, pp.73-81, 1988. ,
Conduite à tenir devant une neuropathie démyélinisante ,
Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies, Muscle Nerve. mars, vol.27, issue.3, pp.285-96, 2003. ,
Autoimmune nodo-paranodopathies of peripheral nerve: the concept is gaining ground, J Neurol Neurosurg Psychiatry. 16 déc, 2017. ,
Evidence for axonal membrane hyperpolarization in multifocal motor neuropathy with conduction block, Brain. mars, vol.125, issue.3, pp.664-75, 2002. ,
Radiculoneuritis syndrome with hyperalbuminosis of cerebrospinal fluid without cellular reaction. Notes on clinical features and graphs of tendon reflexes, Ann Med Interne, vol.150, issue.1, pp.24-32, 1916. ,
Gangliosides contribute to stability of paranodal junctions and ion channel clusters in myelinated nerve fibers, Glia. mai, vol.55, issue.7, pp.746-57, 2007. ,
Acute axonal Guillain-Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides, Ann Neurol. août, vol.38, issue.2, pp.218-242, 1995. ,
Animal model of axonal Guillain-Barré syndrome induced by sensitization with GM1 ganglioside, Ann Neurol. juin, vol.49, issue.6, pp.712-732, 2001. ,
Experimental conduction block induced by serum from a patient with anti-GM1 antibodies, Ann Neurol. avr, vol.31, issue.4, pp.385-90, 1992. ,
Conduction abnormalities induced by sera of patients with multifocal motor neuropathy and anti-GM1 antibodies, Muscle Nerve. juin, vol.16, issue.6, pp.610-615, 1993. ,
IVIG blocks complement deposition mediated by anti-GM1 antibodies in multifocal motor neuropathy, J Neurol Neurosurg Psychiatr. janv, vol.82, issue.1, pp.87-91, 2011. ,
Anti-GM1 antibodies cause complement-mediated disruption of sodium channel clusters in peripheral motor nerve fibers, J Neurosci. 11 avr, vol.27, issue.15, pp.3956-67, 2007. ,
Les nodo-paranodopathies, un concept en plein essor, Pratique Neurologique-FMC. 1 févr, vol.9, issue.1, pp.31-36, 2018. ,
DOI : 10.1016/j.praneu.2017.10.002
Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg, Neurology. 11 mars, vol.82, issue.10, pp.879-86, 2014. ,
Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-Neurofascin 155 antibodies, Neuromuscul Disord. mars, vol.27, issue.3, pp.290-293, 2017. ,
URL : https://hal.archives-ouvertes.fr/hal-01474310
Neurofascin is a glial receptor for the paranodin/Caspr-contactin axonal complex at the axoglial junction, Curr Biol. 5 févr, vol.12, issue.3, pp.217-237, 2002. ,
Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy, J Neuroimmunol, vol.15, issue.1-2, pp.207-219, 2014. ,
Contactin-1 and Neurofascin-155/-186 Are Not Targets of Auto-Antibodies in Multifocal Motor Neuropathy, PLoS ONE, vol.10, issue.7, p.134274, 2015. ,
Pathological findings at the site of conduction block in multifocal motor neuropathy, Ann Neurol. févr, vol.33, issue.2, pp.152-160, 1993. ,
Multifocal motor neuropathy: pathologic alterations at the site of conduction block, J Neuropathol Exp Neurol. févr, vol.63, issue.2, pp.129-166, 2004. ,
Sensory nerve pathology in multifocal motor neuropathy, Ann Neurol. mars, vol.39, issue.3, pp.319-344, 1996. ,
Prevalence of chronic inflammatory demyelinating polyneuropathy in New South Wales, Australia. Ann Neurol. déc, vol.46, issue.6, pp.910-913, 1999. ,
Diaphragmatic dysfunction as the presenting symptom in neuromuscular disorders: A retrospective longitudinal study of etiology and outcome in 30 German patients. Neuromuscular Disorders, vol.9, 2018. ,
Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness, Brain. 1 janv, vol.126, issue.1, pp.186-98, 2003. ,
Magnetic stimulation using a triplestimulation technique in patients with multifocal neuropathy without conduction block, Muscle Nerve. déc, vol.32, issue.6, pp.710-714, 2005. ,
Triple-stimulation technique in multifocal neuropathy with conduction block, Muscle Nerve. mai, vol.35, issue.5, pp.632-638, 2007. ,
Multifocal motor neuropathy: is conduction block essential?, Neurology. 22 août, vol.67, issue.4, pp.558-567, 2006. ,
Multifocal motor neuropathy: a retrospective study of sensory nerve conduction velocities in long-term follow-up of 21 patients, Rev Neurol, vol.165, issue.3, pp.243-251, 2009. ,
Sensory loss in multifocal motor neuropathy: a clinical and electrophysiological study, Muscle Nerve. févr, vol.39, issue.2, pp.131-137, 2009. ,
Axon loss is an important determinant of weakness in multifocal motor neuropathy, J Neurol Neurosurg Psychiatry. juin, vol.77, issue.6, pp.743-750, 2006. ,
Motor unit remodelling in multifocal motor neuropathy: The importance of axonal loss, Clin Neurophysiol, vol.128, issue.10, pp.2022-2030, 2017. ,
Reproducibility, and sensitivity to motor unit loss in amyotrophic lateral sclerosis, of a novel MUNE method: MScanFit MUNE, Clin Neurophysiol. juill, vol.128, issue.7, pp.1380-1388, 2017. ,
How long is IVIg effective in multifocal motor neuropathy?, Neurology. 24 févr, vol.62, issue.4, pp.666-674, 2004. ,
Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment, Brain. 1 août, vol.125, issue.8, pp.1875-86, 2002. ,
Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy, Neurology. mai, vol.48, issue.5, pp.1218-1242, 1997. ,
Diagnostic value of combined magnetic resonance imaging examination of brachial plexus and electrophysiological studies in multifocal motor neuropathy, Vojnosanit Pregl. août, vol.71, issue.8, pp.723-732, 2014. ,
Nerve ultrasound for differentiation between amyotrophic lateral sclerosis and multifocal motor neuropathy, J Neurol, vol.262, issue.4, pp.870-80, 2015. ,
Multifocal motor neuropathy, J Neuroimmunol. avr, vol.115, issue.1-2, pp.4-18, 2001. ,
Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy, JNeurol Neurosurg Psychiatr. juill, vol.85, issue.7, pp.754-762, 2014. ,
Clonality of anti-GM1 IgM antibodies in multifocal motor neuropathy and the GuillainBarré syndrome, J Neurol Neurosurg Psychiatr. mai, vol.86, issue.5, pp.502-506, 2015. ,
Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebocontrolled study, Brain. janv, vol.124, issue.1, pp.145-53, 2001. ,
Intravenous immunoglobulin for multifocal motor neuropathy. Cochrane Database Syst Rev, avr, vol.18, issue.2, p.4429, 2005. ,
, ENMC international workshop: Outcome measures in inflammatory peripheral neuropathies 8-10, vol.23, pp.924-957, 2013.
Raschbuilt Overall Disability Scale for Multifocal motor neuropathy (MMN-RODS), J Peripher Nerv Syst, vol.20, pp.296-305, 2015. ,
The Rasch measurement model in rheumatology: what is it and why use it? When should it be applied, and what should one look for in a Rasch paper?, Arthritis Rheum. 15 déc, vol.57, issue.8, pp.1358-62, 2007. ,
131st ENMC international workshop: selection of outcome measures for peripheral neuropathy clinical trials 10-12, Neuromuscul Disord. févr, vol.16, issue.2, pp.149-56, 2004. ,
Electrodiagnostic criteria for diagnosis of ALS, Clin Neurophysiol. mars, vol.119, issue.3, pp.497-503, 2008. ,
Genotype-phenotype relationship in hereditary amyotrophic lateral sclerosis, Transl Neurodegener, vol.4, p.13, 2015. ,
Distal hereditary motor neuropathy, Rev Neurol, vol.167, issue.11, pp.781-90, 2011. ,
, Neuroimaging Clin N Am, vol.21, issue.4, pp.939-50, 2011.
Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome, Brain. sept, vol.127, pp.2010-2017, 2004. ,
Lewis-Sumner syndrome and multifocal motor neuropathy, Muscle Nerve. janv, vol.31, issue.1, pp.88-94, 2005. ,
URL : https://hal.archives-ouvertes.fr/hal-00094136
Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti-GM1 antibodies: a double-blind, placebo-controlled study, Neurology. mars, vol.44, issue.3, pp.429-461, 1994. ,
Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study, Neurosurgery & Psychiatry. 1 sept, vol.59, issue.3, pp.248-52, 1995. ,
Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study, Neurology, vol.55, issue.9, pp.1256-62, 2000. ,
A controlled trial of intravenous immunoglobulin in multifocal motor neuropathy, J Peripher Nerv Syst. 1 déc, vol.18, issue.4, pp.321-351, 2013. ,
Neuropathies motrices multifocales avec blocs de conduction, profil évolutif sous immunoglobulines intraveineuses, Revue Neurologique. janv, vol.163, issue.1, pp.82-90, 2007. ,
Subcutaneous immunoglobulin in CIDP and MMN: a short-term nationwide study, J Neurol, vol.261, issue.11, pp.2159-64, 2014. ,
How to assess new drugs for neuropathies: advances in trial design and methodology, Curr Opin Neurol, vol.21, issue.5, pp.519-545, 2008. ,
Amélioration d'un cas de neuropathie motrice multifocale avec blocs de conduction sévère, dépendant des immunoglobulines intraveineuses, après adjonction de rituximab au long cours, Revue Neurologique. déc, vol.167, issue.12, pp.916-936, 2011. ,
A syndrome of asymmetric limb weakness with motor conduction block, Neurology. janv, vol.40, issue.1, pp.118-145, 1990. ,
Multifocal motor neuropathy with conduction block: a study of 24 patients, J Neurol Neurosurg Psychiatry. juill, vol.59, issue.1, pp.38-44, 1995. ,
Chronic motor neuropathies: response to interferon-beta1a after failure of conventional therapies, J Neurol Neurosurg Psychiatry. févr, vol.66, issue.2, pp.197-201, 1999. ,
Treatment of multifocal motor neuropathy with interferon-beta1A, Neurology. 11 avr, vol.54, issue.7, pp.1518-1539, 2000. ,
Oral methotrexate as adjunctive therapy in patients with multifocal motor neuropathy on chronic IVIg therapy, J Peripher Nerv Syst. sept, vol.14, issue.3, pp.203-208, 2009. ,
Efficacy of cyclosporine treatment in multifocal motor neuropathy, J Neurol. sept, vol.250, issue.9, pp.1118-1138, 2003. ,
An open label clinical trial of complement inhibition in multifocal motor neuropathy, J Peripher Nerv Syst. juin, vol.16, issue.2, pp.84-91, 2011. ,
Van den Berg L. Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial, Brain. août, vol.130, issue.8, pp.2004-2014, 2007. ,
Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies, Ann Neurol. mars, vol.27, issue.3, pp.316-342, 1990. ,
Multifocal Motor Neuropathy Associated With Infliximab: A Case Report and a Literature Review, Neurologist. juill, vol.22, issue.4, pp.144-150, 2017. ,
, European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society-First Revision, Journal of the Peripheral Nervous System. 1 mars, vol.15, issue.1, pp.1-9, 2010.
Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins. Neurol Neuroimmunol Neuroinflamm, vol.2, p.149, 2015. ,
Treatment of patients with multifocal motor neuropathy with immunoglobulins in clinical practice: the SIGNS registry, Ther Adv Neurol Disord. mai, vol.9, issue.3, pp.165-79, 2016. ,
Multifocal motor neuropathy: decrease in conduction blocks and reinnervation with long-term IVIg, Neurology, vol.12, issue.7, pp.1264-1273, 2004. ,
Multifocal motor neuropathy Association of anti-GM1 IgM antibodies with clinical features, Neurology, vol.75, issue.22, pp.1961-1968, 2010. ,
Multifocal motor neuropathy: clinical and immunological features and response to IVIg in relation to the presence and degree of motor conduction block, J Neurol Neurosurg Psychiatry. juin, vol.72, issue.6, pp.761-767, 2002. ,
Outcome measures in MMN revisited: further improvement needed, J Peripher Nerv Syst. sept, vol.20, issue.3, pp.306-324, 2015. ,
Long term follow up of multifocal motor neuropathy with conduction block under treatment, J Neurol Neurosurg Psychiatry. avr, vol.62, issue.4, pp.391-395, 1997. ,
Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment, Ann Neurol. 1 déc, vol.48, issue.6, pp.919-945, 2000. ,